Swelling, bleeding and even death – women who donate their eggs face many medical risks
By Priyanka Vora,
Scroll.in
| 06. 20. 2018
Last year, shortly after she had donated her eggs for the eighth time since 2009, Shabana Memon* resolved never to undergo the procedure again. “The swelling began after I took the injection for donating eggs at a clinic in Thane,” said 31-year-old Memon, who lives in the Mumbai neighbourhood of Wadala. The infertility clinic paid Memon Rs 28,000 to undergo the procedure and retrieve her eggs. The clinic told her that she had developed an allergy and gave her a course of medicines free of cost. They asserted that the swelling was not related to the procedure. But her condition did not improve. Memon went to another clinic in her neighbourhood and spent Rs 10,000 on treatment.
In April 2018, she visited a clinic in South Mumbai to donate her eggs again, even though the doctor discouraged her from doing so. But she needed the money. Her husband, a zari worker, had been diagnosed with tongue cancer earlier this year. She has three children aged 12,11 and four. “I have five mouths to feed and that can’t be done with...
Related Articles
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...
By Elise Kinsella, ABC News | 06.15.2025
When *Sarah and her partner needed fertility testing, it was Monash IVF that the pair turned to.
"Having a quick browse online, Monash IVF was one of the most prominent ones that came up on Google search and after contacting...
By Hilary Bowman-Smart and Craig Stanbury, The Conversation | 06.12.2025
By Antonio Regalado, MIT Technology Review | 06.05.2025
Brian Armstrong, the billionaire CEO of the cryptocurrency exchange Coinbase, says he’s ready to fund a US startup focused on gene-editing human embryos. If he goes forward, it would be the first major commercial investment in one of medicine’s most...